Recent advances in the development of methyltransferase (MTase) inhibitors against (re)emerging arboviruses diseases dengue and Zika.

[1]  Xi Xu,et al.  Zika Virus Infection and Development of Drug Therapeutics , 2022, Applied Microbiology.

[2]  Peggy Geluykens,et al.  A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction , 2021, Nature.

[3]  B. Gowen,et al.  An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral , 2021, Antiviral Research.

[4]  S. Chanda,et al.  The Compound SBI-0090799 Inhibits Zika Virus Infection by Blocking De Novo Formation of the Membranous Replication Compartment , 2021, Journal of virology.

[5]  A. Moraes,et al.  Non-structural protein 5 (NS5) as a target for antiviral development against established and emergent flaviviruses. , 2021, Current opinion in virology.

[6]  J. E. Muñoz-Medina,et al.  The antiviral effect of metformin on zika and dengue virus infection , 2021, Scientific Reports.

[7]  Hongjuan Zhang,et al.  Identification and Characterization of Zika Virus NS5 Methyltransferase Inhibitors , 2021, Frontiers in Cellular and Infection Microbiology.

[8]  J. D. Beckham,et al.  Arboviral central nervous system infections , 2021, Current opinion in infectious diseases.

[9]  S. Thammapalo,et al.  Ivermectin Accelerates Circulating Nonstructural Protein 1 (NS1) Clearance in Adult Dengue Patients: A Combined Phase 2/3 Randomized Double-blinded Placebo Controlled Trial. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  N. L. Vuong,et al.  Metformin as adjunctive therapy for dengue in overweight and obese patients: a protocol for an open-label clinical trial (MeDO) , 2021, Wellcome open research.

[11]  A. Tuplin,et al.  Small molecule inhibitors possibly targeting the rearrangement of Zika virus Envelope protein. , 2020, Antiviral research.

[12]  J. Smit,et al.  Recent advances in antiviral drug development towards dengue virus. , 2020, Current opinion in virology.

[13]  Dane R. Schalk,et al.  A direct-acting antiviral drug abrogates viremia in Zika virus–infected rhesus macaques , 2020, Science Translational Medicine.

[14]  S. Bharadwaj,et al.  Structure-based screening and validation of bioactive compounds as Zika virus methyltransferase (MTase) inhibitors through first-principle density functional theory, classical molecular simulation and QM/MM affinity estimation , 2020, Journal of biomolecular structure & dynamics.

[15]  C. Poh,et al.  Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus , 2020, Viruses.

[16]  Eduardo H. B. Maia,et al.  Identification of a Potential Zika Virus Inhibitor Targeting NS5 Methyltransferase Using Virtual Screening and Molecular Dynamics Simulations , 2020, J. Chem. Inf. Model..

[17]  D. Barlow,et al.  Design, Synthesis and Discovery of N,N’‐Carbazoyl‐aryl‐urea Inhibitors of Zika NS5 Methyltransferase and Virus Replication , 2019, ChemMedChem.

[18]  A. Ko,et al.  Zika Virus Infection - After the Pandemic. , 2019, The New England journal of medicine.

[19]  T. Kuzuyama,et al.  Recent advances in the biosynthesis of nucleoside antibiotics , 2019, The Journal of Antibiotics.

[20]  M. Shirouzu,et al.  Discovery of a small molecule inhibitor targeting dengue virus NS5 RNA-dependent RNA polymerase , 2019, PLoS neglected tropical diseases.

[21]  M. Izhari,et al.  Molecular docking based design of Dengue NS5 methyltransferase inhibitors , 2019, Bioinformation.

[22]  N. Shrivastava,et al.  Pharmacophore modeling, molecular docking and molecular dynamics simulation for screening and identifying anti-dengue phytocompounds , 2019, Journal of biomolecular structure & dynamics.

[23]  T. E. Colombo,et al.  Co-infection between Zika and different Dengue serotypes during DENV outbreak in Brazil. , 2019, Journal of infection and public health.

[24]  B. Coutard,et al.  Optimization of a fragment linking hit toward Dengue and Zika virus NS5 methyltransferases inhibitors. , 2019, European journal of medicinal chemistry.

[25]  Yongcheng Song,et al.  Discovery, X-ray Crystallography and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease. , 2019, Journal of the American Chemical Society.

[26]  Yingshan Han,et al.  Investigational drugs for the treatment of Zika virus infection: a preclinical and clinical update , 2018, Expert opinion on investigational drugs.

[27]  Chloé Lahondère,et al.  Effects of the Environmental Temperature on Aedes aegypti and Aedes albopictus Mosquitoes: A Review , 2018, Insects.

[28]  J. Chu,et al.  Drug repurposing of quinine as antiviral against dengue virus infection. , 2018, Virus research.

[29]  Denny John,et al.  Dengue infection in India: A systematic review and meta-analysis , 2018, PLoS neglected tropical diseases.

[30]  Y. Orba,et al.  Identification of Compound‐B, a novel anti‐dengue virus agent targeting the non‐structural protein 4A , 2018, Antiviral research.

[31]  J. Robaina,et al.  Co-infection with Zika and Chikungunya viruses associated with fetal death-A case report. , 2018, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[32]  Jessica L Smith,et al.  Characterization and structure‐activity relationship analysis of a class of antiviral compounds that directly bind dengue virus capsid protein and are incorporated into virions , 2018, Antiviral research.

[33]  Emily M. Lee,et al.  Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry , 2018, Cell Discovery.

[34]  A. Jeltsch,et al.  Hijacking DNA methyltransferase transition state analogues to produce chemical scaffolds for PRMT inhibitors , 2018, Philosophical Transactions of the Royal Society B: Biological Sciences.

[35]  Kutty Selva Nandakumar,et al.  Inhibition of dengue viral infection by diasarone‐I is associated with 2’O methyltransferase of NS5 , 2018, European journal of pharmacology.

[36]  M. Soliman,et al.  Zika virus NS5 protein potential inhibitors: an enhanced in silico approach in drug discovery , 2016, Journal of biomolecular structure & dynamics.

[37]  A. Brault,et al.  Modes of Transmission of Zika Virus , 2017, The Journal of infectious diseases.

[38]  Richard J Kuhn,et al.  Zika Virus Structure, Maturation, and Receptors , 2017, The Journal of infectious diseases.

[39]  Hafiz M.N. Iqbal,et al.  Advances in Developing Therapies to Combat Zika Virus: Current Knowledge and Future Perspectives , 2017, Front. Microbiol..

[40]  B. Coutard,et al.  Toward the identification of viral cap-methyltransferase inhibitors by fluorescence screening assay , 2017, Antiviral Research.

[41]  G. Gao,et al.  Structural Biology of the Zika Virus. , 2017, Trends in biochemical sciences.

[42]  Kyle V. Butler,et al.  Development of a S-adenosylmethionine analog that intrudes the RNA-cap binding site of Zika methyltransferase , 2017, Scientific Reports.

[43]  Susan A. Jones,et al.  A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease , 2017, PLoS pathogens.

[44]  D. Kerami,et al.  Modification of S-Adenosyl-l-Homocysteine as Inhibitor of Nonstructural Protein 5 Methyltransferase Dengue Virus Through Molecular Docking and Molecular Dynamics Simulation , 2017, Drug target insights.

[45]  J. Brynda,et al.  Structural basis of Zika virus methyltransferase inhibition by sinefungin , 2017, Archives of Virology.

[46]  J. Low,et al.  Current Status of Dengue Therapeutics Research and Development , 2017, The Journal of infectious diseases.

[47]  Andrea Brancale,et al.  Discovery of novel dengue virus NS5 methyltransferase non-nucleoside inhibitors by fragment-based drug design. , 2017, European journal of medicinal chemistry.

[48]  Sheng-Xiang Lin,et al.  Structural Insight into NS5 of Zika Virus Leading to the Discovery of MTase Inhibitors. , 2016, Journal of the American Chemical Society.

[49]  F. Cheng,et al.  Drug Repurposing: New Treatments for Zika Virus Infection? , 2016, Trends in molecular medicine.

[50]  N. Tamerat,et al.  Aedes aegypti as a Vector of Flavivirus , 2016 .

[51]  J. Neyts,et al.  Towards antiviral therapies for treating dengue virus infections. , 2016, Current opinion in pharmacology.

[52]  Lingaraja Jena,et al.  Virtual Screening for Potential Inhibitors of NS3 Protein of Zika Virus , 2016, Genomics & informatics.

[53]  Xuping Xie,et al.  Adenosine Analog NITD008 Is a Potent Inhibitor of Zika Virus , 2016, Open forum infectious diseases.

[54]  Ruili Huang,et al.  Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen , 2016, Nature Medicine.

[55]  Juan A. Bueren-Calabuig,et al.  Molecular basis of RNA guanine-7 methyltransferase (RNMT) activation by RAM , 2016, Nucleic acids research.

[56]  Emmanuel Fournier,et al.  Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study , 2016, The Lancet.

[57]  Radhakrishnan Padmanabhan,et al.  Dengue Virus Nonstructural Protein 5 (NS5) Assembles into a Dimer with a Unique Methyltransferase and Polymerase Interface , 2016, PLoS pathogens.

[58]  O. Cevik,et al.  Discovery of conjugated thiazolidinone-thiadiazole scaffold as anti-dengue virus polymerase inhibitors. , 2016, Biochemical and biophysical research communications.

[59]  Susan A. Jones,et al.  Identification and Characterization of Novel Broad-Spectrum Inhibitors of the Flavivirus Methyltransferase. , 2015, ACS infectious diseases.

[60]  Susan A. Jones,et al.  Novel Broad Spectrum Inhibitors Targeting the Flavivirus Methyltransferase , 2015, PloS one.

[61]  Hongmin Li,et al.  5'-Silylated 3'-1,2,3-triazolyl Thymidine Analogues as Inhibitors of West Nile Virus and Dengue Virus. , 2015, Journal of medicinal chemistry.

[62]  A. Rodríguez-Morales,et al.  Venezuela: far from the path to dengue and chikungunya control. , 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[63]  J. Connolly,et al.  Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial. , 2014, The Lancet. Infectious diseases.

[64]  Moon Y. F. Tay,et al.  Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin. , 2013, Antiviral research.

[65]  B. D. da Fonseca,et al.  Chloroquine use improves dengue-related symptoms , 2013, Memorias do Instituto Oswaldo Cruz.

[66]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[67]  Dennis E. Hruby,et al.  Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase , 2013, Antimicrobial Agents and Chemotherapy.

[68]  J. Åqvist,et al.  Evaluation of Adamantane Derivatives as Inhibitors of Dengue Virus mRNA Cap Methyltransferase by Docking and Molecular Dynamics Simulations , 2013, Molecular informatics.

[69]  Niranjan Nagarajan,et al.  A Randomized, Double-Blind Placebo Controlled Trial of Balapiravir, a Polymerase Inhibitor, in Adult Dengue Patients , 2012, The Journal of infectious diseases.

[70]  Chelsea M. Byrd,et al.  A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein , 2012, Antimicrobial Agents and Chemotherapy.

[71]  G. Lushington,et al.  Inhibitors of Dengue virus and West Nile virus proteases based on the aminobenzamide scaffold. , 2012, Bioorganic & medicinal chemistry.

[72]  U. Tambunan,et al.  Designing cyclopentapeptide inhibitor as potential antiviral drug for dengue virus ns5 methyltransferase , 2012, Bioinformation.

[73]  S. Harrison,et al.  Small-Molecule Inhibitors of Dengue-Virus Entry , 2012, PLoS pathogens.

[74]  Bimo Ario Tejo,et al.  Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virus , 2011, BMC Bioinformatics.

[75]  D. Sivakumar,et al.  In silico designing and screening of lead compounds to NS5-methyltransferase of dengue viruses. , 2011, Medicinal chemistry (Shariqah (United Arab Emirates)).

[76]  L. Kramer,et al.  Inhibition of Dengue Virus by Targeting Viral NS4B Protein , 2011, Journal of Virology.

[77]  Rajeev Kharb,et al.  Recent advances and future perspectives of triazole analogs as promising antiviral agents. , 2011, Mini reviews in medicinal chemistry.

[78]  Gang Wang,et al.  Small Molecule Inhibitors That Selectively Block Dengue Virus Methyltransferase* , 2010, The Journal of Biological Chemistry.

[79]  Yuan-Ping Pang,et al.  Structure-based discovery of dengue virus protease inhibitors. , 2009, Antiviral research.

[80]  Hongping Dong,et al.  Flavivirus methyltransferase: a novel antiviral target. , 2008, Antiviral research.

[81]  V. Luzhkov,et al.  Virtual screening and bioassay study of novel inhibitors for dengue virus mRNA cap (nucleoside-2'O)-methyltransferase. , 2007, Bioorganic & medicinal chemistry.

[82]  G. Kuno,et al.  Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses , 2007, Archives of Virology.

[83]  T. Ahola,et al.  Inhibitors of virus replication: recent developments and prospects , 2004, Applied Microbiology and Biotechnology.

[84]  H. Schatzmayr.  [Emerging and reemerging viral diseases]. , 2001, Cadernos de saude publica.

[85]  M. Hoehn,et al.  A9145, a new adenine-containing antifungal antibiotic. I. Discovery and isolation. , 1973, The Journal of antibiotics.